Compugen Ltd (XTAE:CGEN)
₪ 6.354 0.234 (3.82%) Market Cap: 568.91 Mil Enterprise Value: 236.21 Mil PE Ratio: 0 PB Ratio: 2.60 GF Score: 34/100

Q4 2021 Compugen Ltd Earnings Call Transcript

Feb 24, 2022 / 01:30PM GMT
Release Date Price: ₪8.67 (-3.57%)
Operator

Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's Fourth Quarter and Full Year 2021 Results Conference Call. (Operator Instructions) An audio webcast of this call is available in the Investors section of Compugen's website, www.cgen.com. As a reminder, today's call is being recorded.

I would now like to introduce Yvonne Naughton, Head of Investor Relations and Corporate Communications. Yvonne, please go ahead.

Yvonne Naughton
Compugen Ltd. - Head of IR & Corporate Communications

Thank you, operator, and thank you all for joining us on the call today. Joining me to present the prepared remarks are Dr. Anat Cohen-Dayag, President and CEO; and Ari Krashin, Chief Financial and Operating Officer. For the Q&A session, we will also be joined by Dr. Henry Adewoye, Chief Medical Officer; and Dr. Eran Ophir, Vice President, Research and Drug Discovery.

Before we begin, we'd like to remind you that during this call, the company may make projections or forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot